0001437749-22-001917.txt : 20220131 0001437749-22-001917.hdr.sgml : 20220131 20220131060856 ACCESSION NUMBER: 0001437749-22-001917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220127 FILED AS OF DATE: 20220131 DATE AS OF CHANGE: 20220131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hornung William Karl CENTRAL INDEX KEY: 0001612066 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37942 FILM NUMBER: 22571121 MAIL ADDRESS: STREET 1: C/O CONTRAVIR PHARMACEUTICALS, INC. STREET 2: 420 LEXINGTON AVE., SUITE 300 CITY: NEW YORK STATE: NY ZIP: 10170 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Diffusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001053691 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300645032 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: (434) 220-0718 MAIL ADDRESS: STREET 1: 2020 AVON COURT STREET 2: SUITE 4 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 FORMER COMPANY: FORMER CONFORMED NAME: RestorGenex Corp DATE OF NAME CHANGE: 20140307 FORMER COMPANY: FORMER CONFORMED NAME: Stratus Media Group, Inc DATE OF NAME CHANGE: 20080722 FORMER COMPANY: FORMER CONFORMED NAME: FERIS INTERNATIONAL, INC. DATE OF NAME CHANGE: 20080228 4 1 rdgdoc.xml FORM 4 X0306 4 2022-01-27 0001053691 Diffusion Pharmaceuticals Inc. DFFN 0001612066 Hornung William Karl 300 E. MAIN ST. SUITE 201 CHARLOTTESVILLE VA 22902 1 Chief Financial Officer Stock Option (Right to Buy) 0.24 2022-01-27 4 A 0 305743 0 A 2032-01-27 Common Stock 305743 305743 D The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022. /s/ William R. Elder, attorney-in-fact for the Reporting Person 2022-01-28